HK Stock Market Move | COASTAL GL(01124) temporary trading halt during trading hours, dropping more than 60% before the halt, giving back all gains made in the last month.
Coastal Home (01124) hit a low of 0.25 Hong Kong dollars during trading, giving back all of its gains from the month. The stock was suspended from trading, and before the suspension, it had fallen by 60.67% to 0.295 Hong Kong dollars, with a total transaction value of 13.69 million Hong Kong dollars.
COASTAL GL (01124) fell to 0.25 Hong Kong dollars during trading, giving up all the gains made in the past month. The stock was suspended from trading with a 60.67% drop to 0.295 Hong Kong dollars before the suspension, with a turnover of 13.69 million Hong Kong dollars.
According to the official website of Coastal Group, the Coastal Real Estate sector, as a professional real estate development and operation platform under Coastal Holdings, was established in Hong Kong in 1990 as the main company "Coastal Green Homes Limited" and listed on the main board of the Hong Kong Stock Exchange in 1997. Its current business areas include urban development and operation services, real estate project development and operation services, etc.
It is reported that COASTAL GL announced its performance for the fiscal year ending March 31, 2025 at the end of June, with revenue of approximately 1.158 billion Hong Kong dollars, a year-on-year increase of about 26.73 times; the company's attributable loss was approximately 382 million Hong Kong dollars, a year-on-year narrowing of 72.7%. It is worth noting that COASTAL GL announced in early January this year that a piece of land in Jinzhou district, Dalian, Liaoning, had been reclaimed, with compensation of 109 million yuan.
Related Articles

CSI PROPERTIES (00497) subsidiary proposes the issuance of additional new notes with a maturity period of three years.

KAISA GROUP (01638): The High Court has ordered the withdrawal of the application.

LEADS BIOLABS-B(09887)LBL-047 has obtained IND approval from the US FDA.
CSI PROPERTIES (00497) subsidiary proposes the issuance of additional new notes with a maturity period of three years.

KAISA GROUP (01638): The High Court has ordered the withdrawal of the application.

LEADS BIOLABS-B(09887)LBL-047 has obtained IND approval from the US FDA.

RECOMMEND